Related Experiment Video

Updated: Jun 22, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

[Aldosterone and kidney damage: clinical implications]

L Del Vecchio1, S Sitia

  • 1Divisione di Nefrologia e Dialisi, Ospedale A. Manzoni, Lecco, Italy. luciadelvecchio@yahoo.com

Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|June 26, 2009
PubMed

Insights

Aldosterone contributes to kidney damage, but aldosterone antagonists show promise in reducing protein in urine. Further long-term studies are needed to confirm safety and effectiveness in chronic kidney disease.

Area of Science:

  • Nephrology
  • Cardiovascular Endocrinology

Context:

  • Aldosterone's role in cardiovascular and renal damage is well-established.
  • Experimental models demonstrate aldosterone's causal link to kidney injury and its reversibility with blockade.
  • Clinical studies since 2001 have investigated aldosterone antagonists for antiproteinuric effects.

Purpose:

  • To review the evidence for aldosterone's contribution to kidney damage.
  • To assess the clinical efficacy and safety of aldosterone antagonists in managing kidney disease.

Summary:

  • Extensive evidence links aldosterone to kidney damage, particularly in salt-sensitive hypertension models.
  • Clinical data support the antiproteinuric effect of aldosterone antagonists when added to renin-angiotensin system inhibitors.
  • Short-term findings suggest this therapeutic strategy is safe and effective, but long-term data are limited.

Impact:

  • Aldosterone antagonists represent a potential therapeutic avenue for mitigating kidney damage.
  • Further large-scale, long-term studies are required to validate this approach across diverse chronic kidney disease populations.
  • This research highlights the need for comprehensive evaluation of aldosterone blockade in kidney disease management.

Related Concept Videos

Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.